This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

30 Jul 2017

Torbay Pharmaceuticals opens new £26 million pharmaceutical manufacturing unit

The new facilities enable to company to further grow and flourish.

Torbay Pharmaceuticals, part of Torbay and South Devon NHS Foundation Trust, has officially opened its new manufacturing unit in Paignton.

The Trust’s Chairman (Sir Richard Ibbotson), Managing Director (Emma Rooth), Technical Director (Mark Andrews), together with staff and other partners, marked the milestone with a celebratory opening ceremony with Sir Richard unveiling a commemorative plaque.

Sir Richard Ibbotson, Chairman of Torbay and South Devon NHS Foundation Trust, said: “We are incredibly proud of Torbay Pharmaceuticals and all that they have achieved over the years. Not only have they created a range of highly skilled career opportunities, but they generate income which directly supports the health and care of local people. This is a first-rate example of what innovation in the NHS can contribute to local communities.

“These fabulous new facilities offer a modern, class-leading environment which will enable Torbay Pharmaceuticals to further grow and flourish. I, on behalf of the Trust Board, cannot thank everyone enough for their hard work in seeing this superb project come to fruition.”

Emma Rooth, Managing Director of Torbay Pharmaceuticals, said: “Torbay Pharmaceuticals is proud to be such a successful part of Torbay and South Devon NHS Foundation Trust. Being part of the NHS enables us to have our finger on the pulse of healthcare needs and respond appropriately with new products, plugging shortages and anticipating the latest developments in medical science.

“Since the establishment of the original pharmaceutical department at Torbay Hospital back in the 1970s, we have grown from strength to strength to meet not only our local population’s needs, but also the needs of the wider NHS and healthcare providers globally.

“The official opening of our new class-leading sterile product facility is a very exciting time for Torbay Pharmaceuticals. By strengthening our production capabilities and ensuring the delivery of high-quality products for our patients through this investment, we have created the platform upon which we can achieve significant growth for the organisation, its people and the region.”

Bryan Taylor, UK Property Director for Balfour Beatty, said: “The official opening of Torbay Pharmaceuticals new manufacturing unit in Paignton marks the completion of 8 years of involvement by Balfour Beatty. Having secured the plot, designed, developed and constructed the facility, the project reflects the all-encompassing skills, expertise and capabilities of Balfour Beatty in providing clients with whole project life cycle solutions.”

Related News